Who is suitable candidate for Stem Cell Treatment?
Stem Cell Treatment is suitable for orthopedic patients suffering from Arthritis, Osteoarthritis, Rheumatoid arthritis, Psoriatic arthritis, stiff knee and related degenerative conditions of tendons, ligaments and cartilage. Among the affected joints could be the hip, knee, shoulder, elbow, ankle, etc.
Treatment is perfectly suitable for patients in stage 1, 2 or 3 – when cartilage is still present in the joint.
For arthritis in stage 4, the treatment options are very limited. Cartilage is already absent in the joint and the usual solution is to replace it with artificial joint. However, stem cell treatment for patients even in stage 4 brought positive results in pain reduction. Especially stage 4 patients with contraindications to total joint replacement surgery (knee replecement - also known as TKR) may still qualify for stem cell treatment.
Other possibilities of using Stem Cell Treatment are
bearing defects of joint cartilage, mostly after injury, osteochondrosis dissecans, joint cartilage disorders (chondromalacia, chondropathy), acute and chronic inflammations of tendons and ligaments, entesopathy (tennis elbow, golf elbow, heel spur, painful groin etc.), healing support in case of injuries or after surgery of ligaments, muscles, tendons and bones, acute damage of meniscus and ligaments of knee joint, acute and sub-acute partial damage of joint ligaments (shoulder, knee, ankle, etc.), sport injuries and overload injuries, neurological disorder (e.g. multiple sclerosis, Alzheimer disease, Parkinson disease, stroke, encephalopathy or cerebral palsy).
Contraindications for the procedure are
any infectious disease, including an acute respiratory infection/cold; actively treated tumour disease and a period of 6 months to 1 year after completion of active treatment (chemotherapy or radiotherapy) of a tumour disease; systemic autoimmune disease; suspicion of a tumour disease; systemic immunosuppressive therapy; continuing use of non-steroidal anti-inflammatory medications and corticosteroids in therapeutic doses within the past 4 weeks – it is necessary to stop taking these medications at least 5 days before the planned collection of lipoaspirate; myocardial infarction or heart failure within the past 3 months; stroke within the past 3 months; pregnancy or nursing; objectively proven osteonecrosis; mental instability or use of psychopharmaceuticals.